{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:25:05Z","timestamp":1793910305583,"version":"4.8.0"},"reference-count":188,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Diabetic cardiomyopathy (DCM) is a distinct myocardial disorder that develops independently of coronary artery disease and hypertension and represents a major contributor to heart failure in patients with diabetes. Beyond hemodynamic alterations, DCM is driven by complex molecular mechanisms involving metabolic dysregulation, mitochondrial dysfunction, inflammation, and fibrotic remodeling. Increasing evidence identifies oxidative stress as a central integrative process linking these pathogenic pathways in the diabetic heart. Chronic hyperglycemia, insulin resistance, and altered substrate utilization promote excessive generation of reactive oxygen species, overwhelming endogenous antioxidant defenses and disrupting myocardial redox homeostasis. Oxidative stress induces direct damage to lipids, proteins, and DNA while simultaneously activating redox-sensitive signaling pathways that amplify inflammation, endothelial dysfunction, cardiomyocyte apoptosis, and fibrosis. In addition, epicardial and visceral adipose tissue have emerged as active contributors to myocardial oxidative stress through paracrine and systemic mechanisms, reinforcing inflammatory and fibrotic crosstalk. This review provides a comprehensive overview of the molecular sources and targets of oxidative damage in DCM, examines the impairment of antioxidant defense systems, and discusses emerging therapeutic strategies aimed at restoring redox balance.<\/jats:p>","DOI":"10.3390\/biom16030470","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:02:43Z","timestamp":1774026163000},"page":"470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets"],"prefix":"10.3390","volume":"16","author":[{"given":"Umberto","family":"Capece","sequence":"first","affiliation":[{"name":"Centro Malattie Endocrine e Metaboliche, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS and Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9617-4491","authenticated-orcid":false,"given":"Davide","family":"Nilo","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Morciano","sequence":"additional","affiliation":[{"name":"Centro Malattie Endocrine e Metaboliche, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS and Universit\u00e0 Cattolica del Sacro Cuore, 00168 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-3443","authenticated-orcid":false,"given":"Roberto","family":"Nilo","sequence":"additional","affiliation":[{"name":"Meditrial Europe, 00198 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Spiezia","sequence":"additional","affiliation":[{"name":"Diagnostic and Therapeutic Medicine Department, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Chiara","family":"Sircana","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Pharmacology, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medical Translational Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Department of Biology, College of Science and Technology, Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, PA 19122, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-2621","authenticated-orcid":false,"given":"Marco Alfonso","family":"Perrone","sequence":"additional","affiliation":[{"name":"Division of Cardiology and CardioLab, Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonilde","family":"Bonfrate","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"},{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-7012","authenticated-orcid":false,"given":"Carlo","family":"Acierno","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Regionale San Carlo, 85100 Potenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-7848","authenticated-orcid":false,"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7761-7533","authenticated-orcid":false,"given":"Alfredo","family":"Caturano","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41591-025-04027-5","article-title":"The Global Macroeconomic Burden of Diabetes Mellitus","volume":"32","author":"Chen","year":"2026","journal-title":"Nat. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12265-023-10470-x","article-title":"Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism","volume":"17","author":"Zhao","year":"2024","journal-title":"J. Cardiovasc. Trans. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yjmcc.2025.06.013","article-title":"Diabetic Cardiomyopathy: Insights into Pathophysiology, Diagnosis and Clinical Management","volume":"206","author":"Chen","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Pafundi, P.C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., and Sasso, F.C. (2021). The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms. Front. Med., 8.","DOI":"10.3389\/fmed.2021.695792"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jin, S., and Kang, P.M. (2024). A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases. Antioxidants, 13.","DOI":"10.3390\/antiox13080923"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Caturano, A., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Iadicicco, I., Donnarumma, M., Galiero, R., and Acierno, C. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants, 14.","DOI":"10.3390\/antiox14010072"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5913374","DOI":"10.1155\/2022\/5913374","article-title":"Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-024-02095-6","article-title":"Redox Regulation: Mechanisms, Biology and Therapeutic Targets in Diseases","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Shaito, A., Aramouni, K., Assaf, R., Parenti, A., Orekhov, A., Yazbi, A.E., Pintus, G., and Eid, A.H. (2022). Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2703105"},{"key":"ref_10","first-page":"5732956","article-title":"The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor","volume":"2020","author":"Schipani","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2147\/DMSO.S245494","article-title":"The Effect of Visceral Abdominal Fat Volume on Oxidative Stress and Proinflammatory Cytokines in Subjects with Normal Weight, Overweight and Obesity","volume":"13","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"ehae666.3728","DOI":"10.1093\/eurheartj\/ehae666.3728","article-title":"Human Epicardial Adipose Tissue-Derived Factors Promote Atrial Endothelial Dysfunction: Role of pro-Inflammatory Cytokines and AT1R\/NADPH Oxidases\/SGLT2 pro-Oxidant Pathway","volume":"45","author":"Fakih","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Galis, P., Bartosova, L., Farkasova, V., Bartekova, M., Ferenczyova, K., and Rajtik, T. (2024). Update on Clinical and Experimental Management of Diabetic Cardiomyopathy: Addressing Current and Future Therapy. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1451100"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yang, H.-M. (2025). GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196758"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-023-01816-5","article-title":"Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: Focus on the mechanisms","volume":"22","author":"Huang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1007\/s00210-025-03980-9","article-title":"A Comprehensive Review on Diabetic Cardiomyopathy (DCM): Histological Spectrum, Diagnosis, Pathogenesis, and Management with Conventional Treatments and Natural Compounds","volume":"398","author":"Abdullah","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","article-title":"Diabetic Cardiomyopathy: Early Diagnostic Biomarkers, Pathogenetic Mechanisms, and Therapeutic Interventions","volume":"9","author":"Huo","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43044-023-00376-z","article-title":"Potential Molecular Mechanism Underlying Cardiac Fibrosis in Diabetes Mellitus: A Narrative Review","volume":"75","author":"Ridwan","year":"2023","journal-title":"Egypt. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Grubi\u0107 Rotkvi\u0107, P., Planini\u0107, Z., Liberati Pr\u0161o, A.-M., \u0160iki\u0107, J., Gali\u0107, E., and Rotkvi\u0107, L. (2021). The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115973"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2174\/1381612828666220720095433","article-title":"The Complex Relationship Between Diabetes and Cardiac Arrhythmias: Pathophysiologyand Mechanisms","volume":"28","author":"Spartalis","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Caturano, A., Galiero, R., Vetrano, E., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., and Sasso, F.C. (2024). Insulin\u2013Heart Axis: Bridging Physiology to Insulin Resistance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158369"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/nutrit\/nuae165","article-title":"Effect of Fatty Acids on Glucose Metabolism and Type 2 Diabetes","volume":"83","author":"Sivri","year":"2025","journal-title":"Nutr. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jdi.13172","article-title":"Fatty Acid Overload to Compromised Oxidative Phosphorylation Activates Inflammation in Type 2 Diabetes: Hidden Beasts and How to Find Them","volume":"11","author":"Lee","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dikalov, S., Panov, A., and Dikalova, A. (2024). Critical Role of Mitochondrial Fatty Acid Metabolism in Normal Cell Function and Pathological Conditions. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126498"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Huang, C., and Zhang, Y. (2021). Reactive Oxygen Species, Glucose Metabolism, and Lipid Metabolism. Oxidative Stress, Springer.","DOI":"10.1007\/978-981-16-0522-2_9"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Sadykhov, N.K., Kartuesov, A.G., Borisov, E.E., Sukhorukov, V.N., and Orekhov, A.N. (2022). The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147863"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/acel.12650","article-title":"The Path from Mitochondrial ROS to Aging Runs through the Mitochondrial Permeability Transition Pore","volume":"16","author":"Rottenberg","year":"2017","journal-title":"Aging Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","article-title":"ROS Production by Mitochondria: Function or Dysfunction?","volume":"43","author":"Palma","year":"2024","journal-title":"Oncogene"},{"key":"ref_29","first-page":"1942086","article-title":"Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy","volume":"2020","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11033-025-11389-z","article-title":"Molecular Pathways of Oxidative Stress in Diabetes: Redox Imbalance and Insulin Pathway Dysregulation","volume":"53","author":"Wani","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70268","DOI":"10.1002\/mco2.70268","article-title":"Oxidative Stress: Signaling Pathways, Biological Functions, and Disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tashkandi, A.J., Gorman, A., McGoldrick Mathers, E., Carney, G., Yacoub, A., Setyaningsih, W.A.W., Kuburas, R., and Margariti, A. (2025). Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073016"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Srivastava, S.P., Kopasz-Gemmen, O., Thurman, A., Rajendran, B.K., Selvam, M.M., Kumar, S., Srivastava, R., Suresh, M.X., Kumari, R., and Goodwin, J.E. (2025). The Molecular Determinants Regulating Redox Signaling in Diabetic Endothelial Cells. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1563047"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., and Medicamento, G. (2022). Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes. Biomolecules, 12.","DOI":"10.3390\/biom12020176"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41366-025-01852-z","article-title":"Heart-Guarding or Heart-Harming? The Dual Role of Epicardial Adipose Tissue in Cardiovascular Health and Disease","volume":"49","author":"Tian","year":"2025","journal-title":"Int. J. Obes."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4070\/kcj.2017.0041","article-title":"Exploring the Crosstalk between Adipose Tissue and the Cardiovascular System","volume":"47","author":"Akoumianakis","year":"2017","journal-title":"Korean Circ. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1111\/jcmm.16941","article-title":"The interplay between mitochondria and store-operated Ca2+ entry: Emerging insights into cardiac diseases","volume":"25","author":"Nan","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"eadp0443","DOI":"10.1126\/sciadv.adp0443","article-title":"Opa1 processing is dispensable in mouse development but is protective in mitochondrial cardiomyopathy","volume":"10","author":"Ahola","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Heart Disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jdi.12250","article-title":"Diabetic Cardiomyopathy and Its Mechanisms: Role of Oxidative Stress and Damage","volume":"5","author":"Liu","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative Stress and Diabetic Complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","article-title":"Diverse functions of cytochrome c in cell death and disease","volume":"31","author":"Zhou","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbabio.2013.01.002","article-title":"Partitioning of superoxide and hydrogen peroxide production by mitochondrial respiratory complex I","volume":"1827","author":"Grivennikovam","year":"2013","journal-title":"Biochim. Biophys. Acta\u2014Bioenerg."},{"key":"ref_44","first-page":"145","article-title":"Sources and implications of NADH\/NAD(+) redox imbalance in diabetes and its complications","volume":"9","author":"Wu","year":"2016","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Morse, P.T., Arroum, T., Wan, J., Pham, L., Vaishnav, A., Bell, J., Pavelich, L., Malek, M.H., Sanderson, T.H., and Edwards, B.F.P. (2024). Phosphorylations and Acetylations of Cytochrome c Control Mitochondrial Respiration, Mitochondrial Membrane Potential, Energy, ROS, and Apoptosis. Cells, 13.","DOI":"10.3390\/cells13060493"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12933-023-01965-7","article-title":"The Role of Oxidative Stress in Diabetes Mellitus-Induced Vascular Endothelial Dysfunction","volume":"22","author":"An","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.bbadis.2017.07.025","article-title":"The Role of NADPH Oxidases in Diabetic Cardiomyopathy","volume":"1864","author":"Hansen","year":"2018","journal-title":"Biochim. Biophys. Acta\u2014Mol. Basis Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-017-0531-9","article-title":"Advanced Glycation End-Products Decreases Expression of Endothelial Nitric Oxide Synthase through Oxidative Stress in Human Coronary Artery Endothelial Cells","volume":"16","author":"Ren","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ye, Z., Wang, S., Wan, Z., Huang, B., and Guo, J. (2025). Targeting NADPH oxidase-driven oxidative stress in diabetic cardiomyopathy: Mechanisms and therapeutic perspectives. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1610429"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1038\/s41598-021-83234-9","article-title":"Association of the Plasma Xanthine Oxidoreductase Activity with the Metabolic Parameters and Vascular Compli-cations in Patients with Type 2 Diabetes","volume":"11","author":"Okuyama","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kotozaki, Y., Satoh, M., Nasu, T., Tanno, K., Tanaka, F., and Sasaki, M. (2023). Human Plasma Xanthine Oxidoreductase Activity in Cardiovascular Disease: Evidence from a Population-Based Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030754"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102195","DOI":"10.1016\/j.redox.2021.102195","article-title":"Xanthine oxidoreductase: A leading actor in cardiovascular disease drama","volume":"48","author":"Polito","year":"2021","journal-title":"Redox Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/bi3000879","article-title":"Aldehyde oxidase functions as a superoxide generating NADH oxidase: An important redox regulated pathway of cellular oxygen radical formation","volume":"51","author":"Kundu","year":"2012","journal-title":"Biochemistry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cvr\/cvq192","article-title":"Mitochondrial aldehyde dehydrogenase and cardiac diseases","volume":"88","author":"Chen","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_55","unstructured":"Wexler, P. (2024). Fate of chemicals following exposure III: Metabolism (biotransformation). Encyclopedia of Toxicology, Academic Press. [4th ed.]."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Harkin, C., Cobice, D., Watt, J., Kurth, M.J., Brockbank, S., Bolton, S., Johnston, F., Strzelecka, A., Lamont, J.V., and Moore, T. (2023). Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.997015"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00125-012-2557-6","article-title":"The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes","volume":"55","author":"Youn","year":"2012","journal-title":"Diabetologia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00018-015-2091-z","article-title":"Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1\/2-NF-\u03baB and JNK-AP-1 signaling pathways","volume":"73","author":"Adamopoulos","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cardfail.2006.11.009","article-title":"High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure","volume":"13","author":"Koyama","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kang, Z., Chen, F., Wu, W., Liu, R., Chen, T., and Xu, F. (2022). UPRmt and coordinated UPRER in type 2 diabetes. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.974083"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"156062","DOI":"10.1016\/j.metabol.2024.156062","article-title":"Targeting Endoplasmic Reticulum Stress as a Potential Therapeutic Strategy for Diabetic Cardiomyopathy","volume":"162","author":"Congur","year":"2025","journal-title":"Metabolism"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101119","DOI":"10.1016\/j.redox.2019.101119","article-title":"Lipoxidation in Cardiovascular Diseases","volume":"23","author":"Gianazza","year":"2019","journal-title":"Redox Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2013.02.021","article-title":"Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice","volume":"60","author":"Huynh","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/10715762.2020.1866756","article-title":"4-Hydroxy-2-Nonenal, a Lipid Peroxidation Product, as a Biomarker in Diabetes and Its Complications: Challenges and Opportunities","volume":"55","author":"Dham","year":"2021","journal-title":"Free Radic. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1582-4934.2006.tb00407.x","article-title":"Protein Carbonylation, Cellular Dysfunction, and Disease Progression","volume":"10","author":"Aldini","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjp.0704495","article-title":"Intracellular Distribution of Peroxynitrite during Doxorubicin Cardiomyopathy: Evidence for Selective Impairment of Myofibrillar Creatine Kinase","volume":"135","author":"Mihm","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.RES.88.5.529","article-title":"Mitochondrial DNA Damage and Dysfunction Associated with Oxidative Stress in Failing Hearts After Myocardial Infarction","volume":"88","author":"Ide","year":"2001","journal-title":"Circ. Res."},{"key":"ref_70","first-page":"398","article-title":"Altered expression of specific antioxidant (SOD1 and SOD2) and DNA repair (XRCC1 and OGG1) genes in patients with newly diagnosed type-2 diabetes mellitus","volume":"49","author":"Suri","year":"2024","journal-title":"Minerva Endocrinol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1111\/bph.12847","article-title":"Glutathione administration reduces mitochondrial damage and shifts cell death from necrosis to apoptosis in ageing diabetic mice hearts during exercise","volume":"171","author":"Golbidi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12933-024-02357-1","article-title":"Mitochondrial Network Remodeling of the Diabetic Heart: Implications to Ischemia Related Cardiac Dysfunction","volume":"23","author":"Rudokas","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.freeradbiomed.2023.09.036","article-title":"P53 Contributes to Cardiovascular Diseases via Mitochondria Dysfunction: A New Paradigm","volume":"208","author":"Wang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wang, X., Liu, R., and Liu, D. (2025). The Role of the MAPK Signaling Pathway in Cardiovascular Disease: Pathophysiological Mechanisms and Clinical Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062667"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Xu, Z., Sun, J., Tong, Q., Lin, Q., Qian, L., Park, Y., and Zheng, Y. (2016). The Role of ERK1\/2 in the Development of Diabetic Cardiomyopathy. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122001"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in Biology and Targeted Therapy: New Insights and Translational Implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB Signaling in Inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_78","first-page":"2","article-title":"Disruption of Nrf2 Synergizes with High Glucose to Cause Heightened Myocardial Oxidative Stress and Severe Cardiomyopathy in Diabetic Mice","volume":"7","author":"He","year":"2012","journal-title":"J. Diabetes Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in Oxidative Stress and Toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular Mechanisms of Diabetic Cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial Adipose Tissue in Contemporary Cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncpcardio0319","article-title":"Epicardial Adipose Tissue: Anatomic, Biomolecular and Clinical Relationships with the Heart","volume":"2","author":"Iacobellis","year":"2005","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.36628\/ijhf.2025.0080","article-title":"Epicardial Adipose Tissue (Pericoronary Adipose Tissue) in Cardiovascular Diseases","volume":"7","author":"Cho","year":"2025","journal-title":"Int. J. Heart Fail."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0305-0491(89)90337-4","article-title":"Adipose Tissue in the Mammalian Heart and Pericardium: Structure, Foetal Development and Biochemical Properties","volume":"94","author":"Marchington","year":"1989","journal-title":"Comp. Biochem. Physiol. Part. B Comp. Biochem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1210\/jc.2013-1265","article-title":"Adult Epicardial Fat Exhibits Beige Features","volume":"98","author":"Sacks","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","article-title":"Dapagliflozin Treatment Is Associated with a Reduction of Epicardial Adipose Tissue Thickness and Epicardial Glucose Uptake in Human Type 2 Diabetes","volume":"22","author":"Cinti","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12933-024-02539-x","article-title":"SGLT2 Inhibition and Adipose Tissue Metabolism: Current Outlook and Perspectives","volume":"23","author":"Morciano","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gruzdeva, O.V., Dyleva, Y.A., Belik, E.V., Sinitsky, M.Y., Stasev, A.N., Kokov, A.N., Brel, N.K., Krivkina, E.O., Bychkova, E.E., and Tarasov, R.S. (2022). Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020129"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6976712","DOI":"10.1155\/2019\/6976712","article-title":"Comparative Proteome Analysis of Epicardial and Subcutaneous Adipose Tissues from Patients with or without Coronary Artery Disease","volume":"2019","author":"Zhao","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Bodenstab, M.L., Varghese, R.T., and Iacobellis, G. (2024). Cardio-Lipotoxicity of Epicardial Adipose Tissue. Biomolecules, 14.","DOI":"10.3390\/biom14111465"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"100657","DOI":"10.1016\/j.jacadv.2023.100657","article-title":"Uncovering the Role of Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","volume":"2","author":"Goldman","year":"2023","journal-title":"JACC Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13098-025-01695-8","article-title":"Insulin Resistance Aggravates Myocardial Fibrosis in Non-Diabetic Hypertensive Patients by Altering the Function of Epicardial Adipose Tissue: A Cardiac Magnetic Resonance Study","volume":"17","author":"Zhu","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cvr\/cvaf056","article-title":"The Role of Epicardial Adipose Tissue Remodelling in Heart Failure with Preserved Ejection Fraction","volume":"121","author":"Eringa","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.hrthm.2022.07.030","article-title":"Unsupervised machine learning reveals epicardial adipose tissue subtypes with distinct atrial fibrosis profiles in patients with persistent atrial fibrillation: A prospective 2-center cohort study","volume":"19","author":"Cui","year":"2022","journal-title":"Heart Rhythm"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCEP.109.912055","article-title":"Pericardial Fat ss Associated with Prevalent Atrial Fibrillation: The Framingham Heart Study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Caturano, A., Galiero, R., and Pafundi, P.C. (2019). Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants. Medicina, 55.","DOI":"10.3390\/medicina55100617"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1113\/JP289263","article-title":"Revisiting Brown Adipose Tissue Whitening: Physiological Mechanisms and Pathophysiological Consequences","volume":"603","author":"Zhao","year":"2025","journal-title":"J. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1113\/JP283721","article-title":"An Obesogenic Diet Impairs Uncoupled Substrate Oxidation and Promotes Whitening of the Brown Adipose Tissue in Rats","volume":"601","author":"Jani","year":"2023","journal-title":"J. Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4161\/21623945.2014.960351","article-title":"Insights into an Adipocyte Whitening Program","volume":"4","author":"Hill","year":"2015","journal-title":"Adipocyte"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1194\/jlr.M079665","article-title":"Brown Adipose Tissue Whitening Leads to Brown Adipocyte Death and Adipose Tissue Inflammation","volume":"59","author":"Kotzbeck","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M800019-JLR200","article-title":"Dead Adipocytes, Detected as Crown-like Structures, Are Prevalent in Visceral Fat Depots of Genetically Obese Mice","volume":"49","author":"Murano","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte Death Defines Macrophage Localization and Function in Adipose Tissue of Obese Mice and Humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12967-016-0962-1","article-title":"Characterisation and comparison of adipose tissue macrophages from human subcutaneous, visceral and perivascular adipose tissue","volume":"14","author":"Kralova","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-025-02688-7","article-title":"Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"24","author":"Menghoum","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Yang, H., Xiong, B., Xiong, T., Wang, D., Yu, W., Liu, B., and She, Q. (2022). Identification of Key Genes and Mechanisms of Epicardial Adipose Tissue in Patients with Diabetes through Bioinformatic Analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.927397"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.31083\/j.rcm2303106","article-title":"Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease","volume":"23","author":"Nevola","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2024.05.065","article-title":"Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes: Insights From the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) Randomized Trial","volume":"84","author":"Manubolu","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12933-025-02912-4","article-title":"Coronary Flow Reserve Increase after 4-Year Dapagliflozin Treatment in Patients with Type 2 Diabetes: The DAPAHEART Follow-up Study","volume":"24","author":"Cinti","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12933-024-02181-7","article-title":"Underlying Mechanisms and Cardioprotective Effects of SGLT2i and GLP-1Ra: Insights from Cardiovascular Magnetic Resonance","volume":"23","author":"Cersosimo","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s44324-024-00036-z","article-title":"Human Adipose Depots\u2019 Diverse Functions and Dysregulations during Cardiometabolic Disease","volume":"2","author":"Ziegler","year":"2024","journal-title":"npj Metab. Health Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/j.2040-4603.2018.tb00046.x","article-title":"Adipose Organ Development and Remodeling","volume":"8","author":"Cinti","year":"2018","journal-title":"Compr. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Galeone, A., Annicchiarico, A., Buccoliero, C., Barile, B., Luciani, G.B., Onorati, F., Nicchia, G.P., and Brunetti, G. (2024). Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179481"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"878760","DOI":"10.1155\/2012\/878760","article-title":"Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation","volume":"2012","author":"Lieb","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Abad-Jim\u00e9nez, Z., L\u00f3pez-Dom\u00e8nech, S., D\u00edaz-R\u00faa, R., Iannantuoni, F., G\u00f3mez-Abril, S.\u00c1., Peria\u00f1ez-G\u00f3mez, D., Morillas, C., V\u00edctor, V.M., and Rocha, M. (2020). Systemic Oxidative Stress and Visceral Adipose Tissue Mediators of NLRP3 Inflammasome and Autophagy Are Reduced in Obese Type 2 Diabetic Patients Treated with Metformin. Antioxidants, 9.","DOI":"10.3390\/antiox9090892"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.23736\/S2724-6507.21.03460-X","article-title":"Proinflammatory Profile of Visceral Adipose Tissue and Oxidative Stress in Severe Obese Patients Carrying the Variant rs4612666 C of NLRP3 Gene","volume":"46","author":"Perri","year":"2021","journal-title":"Minerva Endocrinol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., and An, F. (2014). NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104771"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1159\/000374048","article-title":"Activation in M1 but Not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: A Critical Role of the Calcium Sensing Receptor\/NRLP3 Inflammasome","volume":"35","author":"Liu","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3790721","DOI":"10.1155\/2022\/3790721","article-title":"The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","article-title":"Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)","volume":"94","author":"Turner","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.1300725","article-title":"IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium","volume":"191","author":"Saxena","year":"2013","journal-title":"J. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-Specific TGF-\u03b2\u2013Smad2\/3 Signaling Underlies Cardiac Fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Wu, H., Li, G.N., Xie, J., Li, R., Chen, Q.H., Chen, J.Z., Wei, Z.H., Kang, L.N., and Xu, B. (2016). Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-\u03b2\/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-015-0169-z"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.imbio.2012.05.026","article-title":"IL-1\u03b2 and TGF\u03b22 Synergistically Induce Endothelial to Mesenchymal Transition in an NF\u03baB-Dependent Manner","volume":"218","author":"Maleszewska","year":"2013","journal-title":"Immunobiology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Kaludercic, N., and Di Lisa, F. (2020). Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy. Front. Cardiovasc. Med., 7.","DOI":"10.3389\/fcvm.2020.00012"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4239\/wjd.v5.i6.860","article-title":"Molecular Mechanisms of AGE\/RAGE-Mediated Fibrosis in the Diabetic Heart","volume":"5","author":"Zhao","year":"2014","journal-title":"World J. Diabetes"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"105291","DOI":"10.1016\/j.phrs.2020.105291","article-title":"Corylin Reduces Obesity and Insulin Resistance and Promotes Adipose Tissue Browning through SIRT-1 and \u03923-AR Activation","volume":"164","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tem.2016.04.015","article-title":"Role of Sirtuins in Regulating Pathophysiology of the Heart","volume":"27","author":"Bindu","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.10.126","article-title":"Effect of resveratrol on sirtuins expression and cardiac complications in diabetes","volume":"468","author":"Bagul","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mnfr.201300195","article-title":"Epigenetic Effects of Natural Polyphenols: A Focus on SIRT1-mediated Mechanisms","volume":"58","author":"Ayissi","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","article-title":"New Insights on Oxidative Stress and Diabetic Complications May Lead to a \u201cCausal\u201d Antioxidant Therapy","volume":"26","author":"Ceriello","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","article-title":"Oxidative Stress, Insulin Signaling, and Diabetes","volume":"50","author":"Rains","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","article-title":"Role of Oxidative Stress in Diabetic Complications: A New Perspective on an Old Paradigm","volume":"48","author":"Baynes","year":"1999","journal-title":"Diabetes"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.freeradbiomed.2004.02.074","article-title":"Nrf2 signaling in coordinated activation of antioxidant gene expression","volume":"36","author":"Jaiswal","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abb.2014.12.012","article-title":"The Keap1\u2013Nrf2 System and Diabetes Mellitus","volume":"566","author":"Uruno","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_136","first-page":"11","article-title":"Phytochemical Activators of Nrf2: A Review of Therapeutic Strategies in Diabetes","volume":"55","author":"Qin","year":"2022","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated Reduction of Genes of Oxidative Metabolism in Humans with Insulin Resistance and Diabetes: Potential Role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"150478","DOI":"10.1016\/j.bbrc.2024.150478","article-title":"Mitochondrial Diabetes in Mice Expressing a Dominant-Negative Allele of Nuclear Respiratory Factor-1 (Nrf1) in Pancreatic \u03b2-Cells","volume":"737","author":"Morrish","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41420-025-02461-5","article-title":"NRF1 coordinates mitochondrial adaptations to dampen intracellular ROS and inflammatory responses during ischemia reperfusion","volume":"11","author":"Li","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Hajdys, J., Czarnik, W., Fularski, P., Leszto, K., Majchrowicz, G., Lisi\u0144ska, W., Rysz, J., and Franczyk, B. (2024). The Role of Antioxidants in the Therapy of Cardiovascular Diseases\u2014A Literature Review. Nutrients, 16.","DOI":"10.3390\/nu16162587"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clinthera.2024.12.010","article-title":"Effects of Coenzyme Q10 Supplementation on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"47","author":"Li","year":"2025","journal-title":"Clin. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e002639","DOI":"10.1161\/CIRCHEARTFAILURE.115.002639","article-title":"Coenzyme Q10 and Heart Failure: A State-of-the-Art Review","volume":"9","author":"Sharma","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-024-02183-5","article-title":"Irisin Attenuates Type 1 Diabetic Cardiomyopathy by Anti-Ferroptosis via SIRT1-Mediated Deacetylation of P53","volume":"23","author":"Tang","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/187153012800493521","article-title":"Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy","volume":"12","author":"Spillmann","year":"2012","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Carpintero, R., Gruaz, L., Brandt, K.J., Scanu, A., Faille, D., Combes, V., Grau, G.E., and Burger, D. (2010). HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine Production. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011869"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2008.03.015","article-title":"Inflammation as a Modulator of the HDL Cholesterol-Induced Inteleukin-10 Production by Human Circulating Mononuclear Cells","volume":"202","author":"Coronado","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.108.118919","article-title":"Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor","volume":"53","author":"Spillmann","year":"2009","journal-title":"Hypertension"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00125-006-0244-1","article-title":"Inability of HDL from Type 2 Diabetic Patients to Counteract the Inhibitory Effect of Oxidised LDL on Endothelium-Dependent Vasorelaxation","volume":"49","author":"Foissac","year":"2006","journal-title":"Diabetologia"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e020729","DOI":"10.1161\/JAHA.120.020729","article-title":"Ketone Ester D-\u03b2-Hydroxybutyrate-(R)-1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice","volume":"10","author":"Thai","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic Potential of Targeting Oxidative Stress in Diabetic Cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1017\/S0007114515000227","article-title":"Effect of Vitamin C and Vitamin E Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"113","author":"Ashor","year":"2015","journal-title":"Br. J. Nutr."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5698931","DOI":"10.1155\/2016\/5698931","article-title":"Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?","volume":"2016","author":"Biswas","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbabio.2008.03.029","article-title":"Targeting Lipophilic Cations to Mitochondria","volume":"1777","author":"Murphy","year":"2008","journal-title":"Biochim. Biophys. Acta\u2014Bioenerg."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative Stress: A Concept in Redox Biology and Medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative Stress and Heart Failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CM9.0000000000003230","article-title":"Oxidative Stress in Diabetes Mellitus and Its Complications: From Pathophysiology to Therapeutic Strategies","volume":"138","author":"Chen","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.arres.2025.100142","article-title":"Advancements in Mitochondrial-Targeted Antioxidants: Organelle-Specific Drug Delivery for Disease Management","volume":"17","author":"Nahar","year":"2025","journal-title":"Adv. Redox Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of Bioactive Molecules to Mitochondria In Vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_159","first-page":"100469","article-title":"MitoQ Protects Against Oxidative Stress-Induced Mitochondrial Dysregulation in Human Cardiomyocytes","volume":"13","author":"Parker","year":"2025","journal-title":"J. Mol. Cell. Cardiol. Plus"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","article-title":"Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species with Mito-TEMPO Reduces Diabetic Cardiomyopathy","volume":"90","author":"Ni","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of Tempol and Redox-Cycling Nitroxides in Models of Oxidative Stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","article-title":"Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant","volume":"51","author":"Wind","year":"2008","journal-title":"Hypertension"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Qiu, J., Liu, D., Li, P., Zhou, L., Zhou, L., Liu, X., Zhang, Y., Yuan, M., Tse, G., and Li, G. (2022). NADPH Oxidase Mediates Oxidative Stress and Ventricular Remodeling through SIRT3\/FOXO3a Pathway in Diabetic Mice. Antioxidants, 11.","DOI":"10.3390\/antiox11091745"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Bravo-S\u00e1nchez, E., Pe\u00f1a-Montes, D., S\u00e1nchez-Duarte, S., Saavedra-Molina, A., S\u00e1nchez-Duarte, E., and Montoya-P\u00e9rez, R. (2021). Effects of Apocynin on Heart Muscle Oxidative Stress of Rats with Experimental Diabetes: Implications for Mitochondria. Antioxidants, 10.","DOI":"10.3390\/antiox10030335"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Dama, A., Shpati, K., Daliu, P., Dumur, S., Gorica, E., and Santini, A. (2024). Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation. Nutrients, 16.","DOI":"10.3390\/nu16040507"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00044-025-03508-z","article-title":"Natural Products in Medicinal Chemistry: Targeting Inflammatory Pathways with Plant-Derived Compounds","volume":"35","author":"Amin","year":"2026","journal-title":"Med. Chem. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e1800955","DOI":"10.1002\/mnfr.201800955","article-title":"Isoquercitrin Attenuated Cardiac Dysfunction Via AMPK\u03b1-Dependent Pathways in LPS-Treated Mice","volume":"62","author":"Huang","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Fuloria, S., Mehta, J., Chandel, A., Sekar, M., Rani, N.N.I.M., Begum, M.Y., Subramaniyan, V., Chidambaram, K., Thangavelu, L., and Nordin, R. (2022). A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.820806"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-Lipoic Acid as a Dietary Supplement: Molecular Mechanisms and Therapeutic Potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta\u2014Gen. Subj."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic Mechanisms of Diabetic Heart Disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt\/mTOR and NF\u03baB Signaling Pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13813455.2021.1956976","article-title":"SIRT1: A promising therapeutic target in type 2 diabetes mellitus","volume":"130","author":"Mihanfar","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yexcr.2016.11.016","article-title":"Caloric Restriction Ameliorates Cardiomyopathy in Animal Model of Diabetes","volume":"350","author":"Cohen","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/1573399811666141229151421","article-title":"Physical activity and diabetic cardiomyopathy: Myocardial adaptation depending on exercise load","volume":"10","author":"Bekono","year":"2014","journal-title":"Curr. Diabetes Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac Oxidative Stress in Diabetes: Mechanisms and Therapeutic Potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2217\/nnm.16.26","article-title":"Bioinspired Negatively Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs","volume":"11","author":"Iafisco","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Caturano, A., Nilo, R., Nilo, D., Russo, V., Santonastaso, E., Galiero, R., Rinaldi, L., Monda, M., Sardu, C., and Marfella, R. (2024). Advances in Nanomedicine for Precision Insulin Delivery. Pharmaceuticals, 17.","DOI":"10.3390\/ph17070945"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"101846","DOI":"10.1016\/j.mito.2024.101846","article-title":"Application Research of Novel Peptide Mitochondrial-Targeted Antioxidant SS-31 in Mitigating Mitochondrial Dysfunction","volume":"75","author":"Du","year":"2024","journal-title":"Mitochondrion"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"126999","DOI":"10.1016\/j.molliq.2025.126999","article-title":"Nanoparticle-Enhanced Drug Delivery Systems: An up-to-Date Review","volume":"424","author":"Chenxi","year":"2025","journal-title":"J. Mol. Liq."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Krako Jakovljevic, N., Pavlovic, K., Jotic, A., Lalic, K., Stoiljkovic, M., Lukic, L., Milicic, T., Macesic, M., Stanarcic Gajovic, J., and Lalic, N.M. (2021). Targeting Mitochondria in Diabetes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126642"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a Therapeutic Target for Common Pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Xiong, Z., Liao, Y., Zhang, Z., Wan, Z., Liang, S., and Guo, J. (2025). Molecular Insights into Oxidative-Stress-Mediated Cardiomyopathy and Potential Therapeutic Strategies. Biomolecules, 15.","DOI":"10.3390\/biom15050670"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Choudhury, P., Kosuru, R., and Cai, Y. (2024). Editorial: The Complex Phenotype of Diabetic Cardiomyopathy: Clinical Indicators and Novel Treatment Targets. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1497352"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/17501911.2024.2435257","article-title":"Multi-Omics Insights into the Pathogenesis of Diabetic Cardiomyopathy: Epigenetic and Metabolic Profiles","volume":"17","author":"Zhou","year":"2025","journal-title":"Epigenomics"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2147\/DMSO.S390752","article-title":"Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations","volume":"16","author":"Galiero","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12933-023-01985-3","article-title":"Machine Learning in Precision Diabetes Care and CardiovascularRisk Prediction","volume":"22","author":"Oikonomou","year":"2023","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:11:21Z","timestamp":1774026681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":188,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["biom16030470"],"URL":"https:\/\/doi.org\/10.3390\/biom16030470","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}